KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis

Launched by SEOUL NATIONAL UNIVERSITY HOSPITAL · Apr 25, 2019

Keywords

ClinConnect Summary

The KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis trial is studying different types of kidney diseases, specifically conditions that affect the glomeruli, which are tiny filters in the kidneys. Researchers are gathering information from patients who have undergone kidney biopsies—tests that help diagnose kidney problems. The goal is to better understand these diseases and improve future treatments by collecting long-term data, including genetic information from kidney tissues. This research will help create a valuable resource for doctors and scientists to develop more personalized medicine for kidney disease.

To participate in this trial, patients must be suspected of having a kidney disease and have undergone a biopsy at one of the participating medical centers. This includes both adults and children under 18. However, individuals who have previously received a kidney transplant are not eligible to join. Participants can expect to contribute to important research that may lead to better treatments for kidney diseases in the future. The information gathered will be stored in an easily accessible online database, allowing researchers to work together to find new solutions.

Gender

ALL

Eligibility criteria

• • 1. Inclusion criteria
• • Patient suspected of glomerular disease who received kidney biopsy in participating university medical centers
• • Children (age\<18 years) also included
• • 2. Exclusion criteria - Patients who previously received a kidney transplant